Workflow Orchestration for Drug Contraindications and

Data Characteristics

Contraindication and interaction data originates from drug inserts, pharmacopoeias, clinical guidelines, drug databases (e.g., UpToDate, Lexicomp), and regulatory agency announcements. This data updates frequently, especially with new drug approvals, accumulated adverse event reports, or regulatory changes. Documents are primarily semi-structured or structured. Fields include drug name, active ingredient, contraindications, interacting drugs, interaction type (e.g., pharmacodynamic, pharmacokinetic), clinical manifestations, management recommendations, and evidence levels. Units include dosage (mg, g, IU), frequency (times/day), duration (days, weeks), and concentration (ug/mL).

Constraints Imposed by These Characteristics on Workflow Orchestration

The high update frequency of contraindication and interaction data requires the workflow to have flexible data source integration and efficient index update mechanisms. The semi-structured document structure necessitates specific parsers to extract key field information. This ensures the Q&A system accurately understands relationships between drugs, contraindications, and interacting drugs. For example, parsing generic and brand drug names and identifying interaction severity. The richness and diversity of fields, particularly the standardized handling of units like dosage and frequency, place higher demands on the entity recognition and information extraction modules within the workflow. This prevents incorrect judgments due to inconsistent units. The presence of an evidence level field allows the Q&A system to provide more credible information in its answers. The workflow must pass this metadata to the final Q&A generation module.

Configuration Settings

Configuration Item	Recommended Value	Rationale
`maxContext`	`3000 Tokens`	Accommodates detailed interaction descriptions and multi-drug combination queries.
`Recall count` (Recall Count)	`Top 10 entries` (Top 10)	Ensures coverage of multiple relevant contraindication or interaction pieces of information.
`Similarity threshold` (Similarity Threshold)	`0.78`	Precisely matches drug names and interaction types, reducing false positives.
`Chunk size` (Segment Length)	`500 characters` (500 characters)	Maintains context integrity, avoiding the splitting of critical interaction descriptions.
`Rerank result count` (Reranked Return Count)	`Top 5 entries` (Top 5)	Filters for the most relevant and important contraindication and interaction recommendations.
`HTTP Request Timeout`	`60 seconds` (60 seconds)	Accounts for potential network latency when querying external drug databases.

Common Pitfalls

HTTP requests returning 404 or 500 status codes usually indicate incorrect external drug database API addresses or authentication configuration.
Q&A results lacking critical interacting drug names occur because the entity recognition module failed to correctly extract all drug entities during knowledge base indexing.
When a user query includes multiple drugs, the system only provides contraindication information for one drug. This happens when the multi-entity parsing logic in the workflow does not correctly handle complex queries.

Verification

Query with drug combinations known to have contraindications or interactions. Check if the answer accurately mentions all relevant contraindications and interacting drugs, and provides management recommendations.
Randomly select newly published drug inserts. Ingest and index their contraindication and interaction information into the system. Then, validate through Q&A whether the information is correctly recalled.
Simulate high-concurrency query scenarios. Check if workflow execution time is within an acceptable range. Monitor HTTP Request Timeout logs to assess external interface stability.

The values provided are common starting points and should be measured against the reader's own samples.

Question material comes from public community discussions. Configuration values are common starting points and should be measured against your own samples. Verified on 2026-09-21.